Recently Added |View All
Women treating high risk indicated patients (WHiP) conference
In April 2024, WellSpan York Hospital hosted the second annual Women Treating High Risk Indicated Patients (WHiP) conference, bringing together 21 female cardiologists while streaming to more than 75 cardiologists in five countries
Maximizing VAD benefits: The critical role of timely referral
Many heart failure patients who need a ventricular assist device (VAD) don’t get one until their condition has advanced too far. Learn the nuances of advanced heart failure symptoms and when to refer patients for VAD evaluation.
Catching abdominal aortic aneurysms before they burst
An abdominal aortic aneurysm (AAA) screening is recommended for men ages 65-75 who are or were smokers. Women with risk factors like a family history may also benefit. Find out who to screen for AAA, how to manage it and when to refer.
Should we do genetic screening for CVD and other diseases?
Screening asymptomatic patients for CVD-causing genes can save lives, but many scientific and ethical questions must be answered before we know it’s worth it.
One-of-a-kind stroke prevention for patients with Afib
WellSpan is the first-in-the-US to anchor an in-lab 4D-CT imaging modality to ensure devices are positioned properly.
TAVR Q&A with Dr. James Harvey
Dr. Harvey is the “doctor that other doctors come to” to learn the most advanced technique for TAVR. He’s been all over the world, in fact, teaching other interventional cardiologists his approach, which has become the standard of care for this procedure.